Hyperadrenocorticism / Cushing's disease (rare in cats)

Hyperadrenocorticism, commonly known as Cushing's disease, is a serious endocrine disorder characterized by chronic excessive production of cortisol by the adrenal glands. While relatively common in dogs, this condition occurs rarely in cats, making it one of the more unusual hormonal diseases veterinarians encounter in feline practice. The condition results from either a tumor in the pituitary gland that overstimulates the adrenal glands, a tumor within the adrenal gland itself that produces cortisol autonomously, or rarely from prolonged administration of corticosteroid medications. When Cushing's disease does occur in cats, it typically presents with challenging clinical signs and is frequently accompanied by concurrent diabetes mellitus, complicating both diagnosis and management.

The underlying mechanism of hyperadrenocorticism involves disruption of the normal feedback system controlling cortisol production. Under normal circumstances, the hypothalamus releases corticotropin-releasing hormone, which stimulates the pituitary gland to produce adrenocorticotropic hormone, which in turn stimulates the adrenal glands to produce cortisol. Rising cortisol levels normally signal the hypothalamus and pituitary to reduce stimulation, maintaining hormone levels within a healthy range. In Cushing's disease, this feedback loop fails because either a pituitary tumor produces ACTH regardless of cortisol levels, or an adrenal tumor produces cortisol independent of ACTH stimulation. The resulting chronic cortisol excess affects virtually every body system.

The impact of hyperadrenocorticism on affected cats is profound and multisystemic. Cortisol excess causes insulin resistance leading to diabetes mellitus in the majority of feline cases, creating a dual endocrine crisis that severely impacts quality of life. The hormone's effects on protein metabolism result in muscle wasting and skin fragility that can become extreme. Immunosuppression increases susceptibility to infections that may become severe. Abnormal fat distribution changes body appearance. Cardiovascular effects may develop. The combination of these effects typically makes affected cats obviously ill, though the gradual onset sometimes delays recognition of the severity of disease. Without treatment, the condition progressively worsens and significantly shortens life expectancy.

Despite its serious nature, hyperadrenocorticism in cats can sometimes be managed, though treatment presents greater challenges than in dogs. Surgical removal of adrenal tumors offers the best chance of cure when tumors are resectable, though surgical risk is elevated due to the debilitated state of most affected cats. Pituitary-dependent disease is more difficult to treat, with options including radiation therapy for the pituitary tumor or medical management aimed at reducing cortisol production. The strong association between feline Cushing's disease and diabetes mellitus means that managing blood glucose is a critical component of treatment regardless of the approach to the primary disease. Early recognition of this rare condition improves treatment options and outcomes, making awareness of its clinical presentation important despite its uncommon occurrence.

The primary causes of naturally occurring hyperadrenocorticism in cats involve tumors affecting either the pituitary gland or the adrenal glands themselves. Pituitary-dependent hyperadrenocorticism, accounting for approximately eighty percent of feline cases, results from a tumor in the pituitary gland that secretes excessive adrenocorticotropic hormone. This ACTH overstimulates both adrenal glands, causing them to enlarge bilaterally and produce excess cortisol. These pituitary tumors may be small microadenomas or larger macroadenomas that can eventually cause neurological signs from compression of surrounding brain structures. Adrenal-dependent hyperadrenocorticism, responsible for the remaining cases, results from a tumor within one adrenal gland that produces cortisol autonomously without regard to normal regulatory signals. These adrenal tumors may be benign adenomas or malignant carcinomas.

Genetic and hereditary factors have not been clearly identified in feline hyperadrenocorticism, unlike some other endocrine disorders with recognized breed predispositions. The tumors underlying Cushing's disease appear to arise spontaneously without clear genetic transmission patterns. No specific breeds have been definitively associated with increased risk, though the relative rarity of the condition in cats makes epidemiological patterns difficult to establish. Some cases may have underlying genetic predisposition to tumor development that has not yet been characterized. The lack of identified hereditary factors means that targeted genetic screening or breeding recommendations are not currently available, and cases are managed individually as they arise.

Iatrogenic hyperadrenocorticism represents a distinct category caused by medical treatment rather than naturally occurring tumors. Prolonged administration of corticosteroid medications, whether oral, injectable, or topical, can suppress the normal hypothalamic-pituitary-adrenal axis while simultaneously producing all the clinical effects of cortisol excess. Cats requiring chronic steroid therapy for conditions such as inflammatory bowel disease, allergies, or autoimmune disorders face risk of this complication. Iatrogenic Cushing's syndrome differs from naturally occurring disease in that it resolves when the exogenous steroids are discontinued, though this must be done gradually to allow recovery of the suppressed adrenal glands. Recognition that a cat's symptoms result from prescribed medications rather than endogenous hormone overproduction changes the management approach entirely.

Risk factors for developing hyperadrenocorticism in cats include middle to older age, with most cases diagnosed in cats over ten years old. Female cats appear to be affected more frequently than males in most published case series, though the reason for this sex predilection remains unclear. Cats with chronic conditions requiring long-term corticosteroid therapy face iatrogenic risk. No specific environmental or lifestyle factors have been identified that increase natural tumor development risk. The concurrent development of diabetes mellitus in most affected cats may reflect either a consequence of or shared risk factor with Cushing's disease. Given the rarity of the condition, comprehensive risk factor analysis remains challenging.

At the cellular and physiological level, the pathogenesis of hyperadrenocorticism involves tumor cells that escape normal regulatory control. In pituitary tumors, corticotroph cells develop mutations allowing continued ACTH production despite high circulating cortisol levels that would normally suppress their function. These cells may also proliferate, forming expanding tumors. In adrenal tumors, adrenocortical cells acquire autonomous cortisol-producing capacity, secreting hormone without ACTH stimulation. The chronic cortisol excess then affects target tissues throughout the body. Cortisol antagonizes insulin action, causing glucose intolerance and diabetes. It promotes protein catabolism, causing muscle wasting and skin fragility. It suppresses immune function, increasing infection susceptibility. It affects fat distribution, mineral metabolism, cardiovascular function, and numerous other physiological processes, producing the characteristic multisystemic clinical syndrome.

Early warning signs of hyperadrenocorticism in cats often overlap substantially with diabetes mellitus symptoms, as the two conditions frequently coexist. Owners may notice increased thirst and urination developing gradually over weeks to months. Appetite may increase initially as glucose regulation becomes impaired. Weight changes occur, with some cats losing weight despite increased appetite while others gain weight or show abnormal fat distribution. Coat quality may decline, becoming dull, unkempt, or showing increased shedding. Subtle changes in activity level and behavior sometimes precede more obvious physical signs. Because these early symptoms are nonspecific and develop gradually, significant disease progression often occurs before veterinary evaluation is sought. The hidden nature of feline illness further delays recognition.

Common symptoms of established hyperadrenocorticism in cats present a characteristic clinical picture that experienced veterinarians recognize. Polyuria and polydipsia, meaning increased urination and water consumption, occur in the vast majority of cases. A pot-bellied appearance develops from fat redistribution combined with muscle wasting and hepatomegaly. The skin becomes noticeably fragile, tearing easily with minimal trauma during handling or from normal activities. Some cats develop patchy hair loss or fail to regrow hair after shaving. Muscle wasting becomes apparent, particularly over the spine and hindquarters. Lethargy and weakness reflect both metabolic derangements and muscle loss. Weight changes continue to progress. The concurrent diabetes often present contributes additional symptoms including polyphagia and further metabolic imbalance.

Behavioral changes accompanying feline Cushing's disease reflect the systemic impact of chronic cortisol excess. Affected cats typically become less active, spending more time resting and showing reduced interest in play or exploration. Appetite changes may include increased hunger from diabetes or reduced intake as cats feel generally unwell. Social interactions often decrease as cats become withdrawn. Some cats become irritable or display altered temperament. Grooming behavior may decrease, contributing to poor coat condition. Litter box habits change with increased urination volume. The gradual onset of behavioral changes often leads owners to attribute them to normal aging rather than recognizing them as disease symptoms.

Physical signs observable during examination reveal the extent of hormonal disruption. The pot-bellied or pendulous abdomen from hepatomegaly and muscle wall weakness is often striking. Skin fragility may be dramatic, with skin tearing during normal handling for examination. Hair coat changes include alopecia, failure to regrow shaved hair, and overall poor coat quality. Muscle atrophy is palpable along the spine and limbs. Skin may appear thin enough to see underlying blood vessels. Some cats develop skin infections or poor wound healing. Blood pressure elevation is common. Hepatomegaly is frequently palpable. Body condition reflects the catabolic effects of cortisol excess. The combination of physical findings creates a recognizable syndrome in advanced cases.

Symptom progression in hyperadrenocorticism follows a chronic worsening pattern without treatment. Early nonspecific symptoms gradually intensify and multiply as cortisol levels remain elevated. Skin fragility worsens progressively, potentially leading to spontaneous skin tears or difficulty healing minor wounds. Muscle wasting advances, causing increasing weakness. Diabetes becomes increasingly difficult to control as insulin resistance intensifies. Susceptibility to infections increases, with urinary tract infections, skin infections, and other opportunistic problems becoming more frequent and severe. Some cats develop neurological signs if pituitary tumors enlarge enough to compress surrounding brain structures. The overall trajectory is one of declining health and quality of life without intervention.

Emergency symptoms requiring immediate veterinary attention include any acute deterioration in a cat suspected or known to have Cushing's disease. Severe skin tears or spontaneous wounds require urgent care to prevent complications and manage pain. Signs of infection including fever, lethargy, and localized inflammation may indicate serious illness in these immunocompromised cats. Neurological signs such as behavior changes, seizures, circling, or altered consciousness suggest pituitary tumor effects requiring immediate evaluation. Signs of diabetic crisis including vomiting, severe lethargy, and rapid breathing indicate diabetic ketoacidosis. Collapse or acute weakness demands emergency assessment. The fragile state of cats with Cushing's disease means that problems can escalate rapidly, warranting prompt attention to concerning changes.

Initial veterinary examination for suspected hyperadrenocorticism involves comprehensive assessment correlating clinical signs with history and physical findings. The veterinarian gathers detailed history regarding symptom duration and progression, water consumption and urination patterns, appetite changes, and any medications including topical preparations the cat has received. Physical examination focuses on identifying characteristic findings including abdominal distension, muscle wasting, skin fragility, coat changes, and hepatomegaly. Blood pressure measurement may reveal hypertension common in affected cats. The constellation of typical clinical signs in a middle-aged to older cat creates suspicion warranting diagnostic testing. However, because Cushing's disease is rare in cats, other more common conditions must also be considered.

Diagnostic testing for hyperadrenocorticism involves several laboratory evaluations and hormone assays. Routine blood work typically reveals specific abnormalities including elevated liver enzymes, particularly ALP and ALT, elevated cholesterol, and most notably hyperglycemia from concurrent diabetes in the majority of feline cases. Urinalysis commonly shows dilute urine and glucosuria. Specific hormone testing to confirm Cushing's disease includes measurement of cortisol levels and dynamic tests evaluating adrenal gland responsiveness. The low-dose dexamethasone suppression test measures whether cortisol production is appropriately suppressed following administration of synthetic glucocorticoid, which fails to suppress cortisol in Cushing's disease. ACTH stimulation testing evaluates adrenal reserve. Endogenous ACTH measurement helps differentiate pituitary-dependent from adrenal-dependent disease. Abdominal ultrasound evaluates adrenal gland size and appearance, identifying tumors or bilateral enlargement.

Differential diagnosis for cats presenting with Cushing's-like symptoms must consider other conditions producing similar clinical pictures. Diabetes mellitus alone causes many overlapping symptoms and frequently coexists with Cushing's, complicating differentiation. Hyperthyroidism in older cats causes weight loss, increased appetite, and metabolic derangements. Chronic kidney disease produces increased thirst and urination. Liver disease may cause abdominal distension. Other causes of skin fragility, though less common, require consideration. Iatrogenic Cushing's from prescribed steroids must be distinguished from naturally occurring disease through careful medication history. The concurrent conditions common in feline Cushing's disease mean that accurate diagnosis often requires ruling in the disease through hormone testing rather than simply ruling out alternatives.

Diagnosis confirmation requires integration of clinical signs with supportive laboratory findings and definitive hormone test results. The combination of characteristic symptoms, appropriate physical examination findings, and failure of cortisol suppression on dexamethasone testing establishes the diagnosis. Differentiation between pituitary-dependent and adrenal-dependent disease guides treatment planning and requires additional testing. Endogenous ACTH levels are elevated in pituitary-dependent and suppressed in adrenal-dependent disease. Imaging studies help characterize the underlying tumor. Abdominal ultrasound reveals unilateral adrenal enlargement with contralateral atrophy in adrenal-dependent cases, versus bilateral adrenal enlargement in pituitary-dependent disease. Advanced imaging with CT or MRI may be necessary to visualize pituitary tumors. Complete diagnostic evaluation establishes both the diagnosis and tumor localization needed for treatment planning.

Emergency treatment for cats with hyperadrenocorticism addresses acute complications while stabilizing the patient for definitive therapy. Cats presenting with diabetic ketoacidosis require intensive care with intravenous fluids, insulin therapy, and electrolyte management as immediate priorities. Severe skin wounds from fragility-related tears need careful cleaning, protection, and pain management. Infections require prompt antimicrobial therapy, with culture and sensitivity testing guiding antibiotic selection when possible. Supportive care including nutritional support, correction of dehydration, and management of concurrent conditions stabilizes critically ill cats. Emergency management focuses on stabilization rather than definitive treatment of the underlying Cushing's disease, which requires a more considered approach once the patient is stable.

Medical management of feline hyperadrenocorticism aims to reduce cortisol production or block its effects. Trilostane, a reversible inhibitor of cortisol synthesis, has become the most commonly used medical treatment for feline Cushing's disease. This medication requires careful dose titration based on cortisol monitoring and clinical response, with adjustments made over weeks to months to achieve optimal control. Metyrapone, another cortisol synthesis inhibitor, serves as an alternative in some cases. Medical management rarely achieves complete disease control but can improve clinical signs and quality of life. The concurrent diabetes frequently improves as cortisol levels decrease, though most cats still require insulin therapy. Medical treatment typically continues lifelong, with regular monitoring guiding ongoing dose adjustments.

Surgical treatment offers the best chance of cure for adrenal-dependent hyperadrenocorticism when the tumor is amenable to resection. Adrenalectomy, surgical removal of the affected adrenal gland, eliminates the source of cortisol excess in cases caused by unilateral adrenal tumors. However, surgical risk is significantly elevated in cats debilitated by Cushing's disease, with skin fragility complicating wound healing and immunosuppression increasing infection risk. Careful patient stabilization before surgery and meticulous surgical technique improve outcomes. Post-operative supplementation with cortisol is necessary until the remaining adrenal gland recovers function. For pituitary-dependent disease, surgery to remove the pituitary tumor is technically challenging and rarely performed in cats. Radiation therapy directed at pituitary tumors represents an alternative approach that can reduce tumor size and hormone production.

Supportive care addresses the multisystemic effects of cortisol excess and accompanying conditions. Diabetes management remains critical, with insulin therapy required in most cases and doses adjusted as Cushing's treatment affects insulin sensitivity. Skin care involves protecting fragile skin from trauma, treating any wounds that develop, and monitoring for infection. Nutritional support with high-quality protein helps combat muscle wasting. Environmental modifications reduce injury risk for weakened cats. Blood pressure management may be necessary if hypertension develops. Treatment of concurrent infections requires appropriate antimicrobial therapy. Overall supportive care significantly impacts quality of life even when definitive treatment of the underlying disease proves challenging.

Alternative and complementary treatments play limited roles in managing feline hyperadrenocorticism, as this serious condition requires conventional medical or surgical intervention. Nutritional strategies supporting overall health complement primary treatment. Stress reduction through environmental enrichment and calm handling may provide modest benefit. Some practitioners explore complementary approaches for supportive care, though evidence for specific alternative treatments remains lacking. The primary focus must remain on controlling cortisol excess through proven medical or surgical means, with complementary approaches serving adjunctive roles at most.

Treatment decisions for feline Cushing's disease involve weighing multiple complex factors. The rarity of the condition means that many veterinarians have limited experience managing it, potentially warranting referral to specialists. Treatment costs for medical management are ongoing, while surgical intervention carries significant upfront expense plus elevated perioperative risk. The cat's overall health status, concurrent conditions, and predicted response to treatment influence recommendations. Tumor type affects treatment options, with adrenal tumors more amenable to surgical cure than pituitary tumors. Owner circumstances including ability to manage ongoing medication, monitoring appointments, and potential complications factor into realistic planning. Honest discussion of prognosis helps owners make informed decisions aligned with their values and capabilities.

Recovery timeline for cats treated for hyperadrenocorticism varies considerably based on the treatment approach and individual patient factors. Cats undergoing successful adrenalectomy for adrenal tumors typically require several days to weeks of post-surgical recovery, with gradual improvement in clinical signs over the following months as cortisol-related damage slowly resolves. Medical management with trilostane produces gradual improvement over weeks to months as cortisol levels decrease, though complete normalization of clinical signs is uncommon. Skin fragility improves slowly, with healing of existing wounds and reduced susceptibility to new tears. Muscle mass gradually rebuilds with reduced catabolic drive. Diabetes control often improves but rarely resolves completely. The recovery trajectory depends heavily on the degree of disease control achieved and the extent of damage that occurred before treatment.

Post-treatment care requirements remain intensive throughout the recovery and maintenance periods. Cats on medical management require regular cortisol monitoring to guide dose adjustments, typically every few weeks initially then less frequently once stable. Physical examination and laboratory work assess overall health and detect complications. Diabetes management continues with insulin therapy and glucose monitoring. Skin protection remains important during the vulnerable recovery period. Activity should increase gradually as strength returns. Nutritional support with high-protein diets helps rebuild muscle mass. Multiple follow-up appointments ensure treatment remains effective and complications are caught early. The management burden of feline Cushing's disease continues long-term even after initial recovery.

Prognosis factors influencing outcomes in feline hyperadrenocorticism include tumor type, disease severity at diagnosis, response to treatment, and presence of concurrent conditions. Cats with resectable adrenal tumors that undergo successful surgery have the best prognosis, with potential for complete cure. Adrenal carcinomas carry worse prognosis than adenomas due to metastatic potential. Pituitary-dependent disease is more difficult to control, with prognosis depending on tumor behavior and treatment response. Severe skin fragility and extensive muscle wasting at diagnosis suggest advanced disease with more guarded outlook. Concurrent diabetes complicates management but does not preclude successful treatment. Early diagnosis and treatment generally improve outcomes compared to advanced disease.

Long-term outlook for cats with hyperadrenocorticism remains guarded overall, though individual outcomes vary widely. Cats achieving good disease control through surgical cure or effective medical management may enjoy reasonable quality of life for months to years. However, the serious nature of the underlying tumor process and systemic effects of chronic cortisol excess mean that many cats face significant ongoing challenges. Pituitary tumors may continue to grow despite treatment, eventually causing neurological deterioration. Adrenal carcinomas may metastasize. Medical management rarely achieves complete disease control. The concurrent diabetes requires lifelong management. Realistic expectations acknowledge that treatment aims to improve quality and extend survival rather than cure the disease in most cases, while celebrating successful outcomes when they occur.

Primary prevention of naturally occurring hyperadrenocorticism is not currently possible, as the underlying tumors develop spontaneously without identified preventable risk factors. Unlike some conditions with clear genetic predispositions or environmental triggers amenable to intervention, the causes of pituitary and adrenal tumors in cats remain unclear and unpreventable with current knowledge. General measures supporting overall health through good nutrition, regular veterinary care, and appropriate lifestyle management provide nonspecific benefit but cannot specifically prevent Cushing's disease development. Research into tumor development mechanisms may eventually identify preventive strategies, but none are available today.

Prevention of iatrogenic hyperadrenocorticism, caused by prescribed corticosteroid medications, is achievable through careful medical management. Using corticosteroids only when truly necessary and at the lowest effective doses minimizes risk. Exploring alternative treatments for conditions commonly managed with steroids, when safe and effective alternatives exist, reduces exposure. When steroids are required long-term, using every-other-day dosing when possible provides some protection. Monitoring cats on chronic steroid therapy for developing Cushing's symptoms enables early intervention. Gradual tapering when discontinuing steroids prevents adrenal crisis. Clear communication between veterinarians and owners about the risks of long-term steroid use supports informed decision-making about treatment approaches.

Dietary approaches play no known role in preventing hyperadrenocorticism, though maintaining overall health through good nutrition provides general benefit. High-quality nutrition supports metabolic health and immune function. Preventing obesity through appropriate caloric intake may provide nonspecific benefit, though no direct connection to Cushing's prevention exists. For cats already diagnosed with Cushing's disease, nutritional support becomes important for managing the condition's effects, but diet cannot prevent tumor development.

Health maintenance through regular veterinary care enables early detection when prevention is not possible. Annual or twice-yearly wellness examinations in middle-aged and older cats allow veterinarians to identify early symptoms that might otherwise be attributed to normal aging. Routine blood work may reveal abnormalities suggesting hormonal imbalance. Early diagnosis, while not prevention, enables treatment before severe complications develop. Building relationships with veterinary teams familiar with individual cats' normal parameters facilitates recognition of changes. Owner awareness of symptoms to watch for prompts earlier presentation for evaluation.

Early intervention when symptoms develop represents the closest approximation to prevention of severe disease complications. Recognizing early warning signs including increased thirst, changes in appetite or weight, coat quality decline, or developing skin problems prompts veterinary evaluation. Investigating symptoms promptly rather than waiting for progression enables earlier diagnosis. Beginning treatment while disease is less advanced generally improves outcomes. For cats on chronic corticosteroid therapy, early recognition of developing Cushing's symptoms allows medication adjustment before severe problems develop. While the underlying disease cannot be prevented, its worst consequences can sometimes be mitigated through vigilant attention and early action.

Daily management for cats living with hyperadrenocorticism requires attention to multiple aspects of care simultaneously. Medication administration follows prescribed schedules, whether for Cushing's treatment itself or concurrent diabetes management. Trilostane or other prescribed medications must be given consistently, typically with food, at the same times daily. Insulin for diabetes requires careful timing relative to meals. Monitoring food intake and water consumption provides information about disease control. Daily observation for new skin tears, signs of infection, or other complications enables prompt attention to problems. Behavioral changes potentially indicating disease progression or treatment complications warrant note. Maintaining detailed records helps track patterns and provides valuable information for veterinary consultations.

Home environment modifications protect fragile cats from injury while maintaining quality of life. Soft bedding throughout resting areas prevents pressure injuries on thin skin. Removing obstacles and sharp edges reduces accidental trauma risk. Low-sided litter boxes enable easy access without climbing. Keeping nails trimmed prevents self-inflicted scratches. Maintaining consistent room layouts helps weakened cats navigate safely. Providing accessible food and water stations eliminates the need for jumping or climbing. Creating calm, predictable environments reduces stress. Climate control prevents temperature extremes that stressed cats tolerate poorly. These modifications support comfort and safety while allowing cats to maintain as much normal activity as possible.

Maintaining quality of life for cats with Cushing's disease focuses on comfort and contentment despite chronic illness. Gentle interaction and affection meet emotional needs without risking skin injury from rough handling. Quiet play appropriate to reduced energy levels provides mental stimulation. Comfortable resting spots in favorite locations maintain normal routines. Pain management addresses discomfort from wounds or related conditions. Appetite stimulation helps if eating decreases. Regular grooming assistance compensates for reduced self-care ability. Quality of life assessment considers the balance between manageable symptoms and meaningful enjoyment of life. When quality significantly declines despite treatment, difficult conversations about end-of-life care become necessary.

Ongoing monitoring ensures treatment remains effective and catches complications early. Regular veterinary rechecks assess clinical status and adjust treatment as needed. Cortisol monitoring guides medical management dose adjustments. Blood glucose monitoring tracks diabetes control. Blood pressure measurement detects hypertension requiring intervention. Laboratory work monitors liver enzymes and overall metabolic status. Physical examination identifies new skin lesions, muscle wasting progression, or other concerning changes. Between appointments, owners watch for increased thirst, behavioral changes, new wounds, or signs of infection warranting earlier consultation. The monitoring burden is substantial but necessary for managing this complex condition.

Caregiver support resources help owners navigate the challenges of managing a cat with Cushing's disease. Veterinary team members provide ongoing guidance and emotional support through the difficult journey. Specialist consultations, when available, offer expertise with this uncommon condition. Online communities connect owners facing similar challenges, though the rarity of feline Cushing's makes specific support groups uncommon. Financial planning helps manage the ongoing costs of monitoring and treatment. Respite arrangements allow needed breaks from intensive caregiving. Counseling resources help process difficult emotions including grief over declining health and difficult end-of-life decisions. Recognizing caregiver fatigue and addressing it proactively supports both owner wellbeing and quality of care for the cat.

High-risk breeds for hyperadrenocorticism have not been definitively identified in cats, unlike some other endocrine disorders with clear breed predispositions. The rarity of feline Cushing's disease limits epidemiological studies capable of identifying breed associations. Published case series have not consistently demonstrated increased risk in specific breeds. The condition appears to occur sporadically across the feline population without strong genetic concentration in particular breeds. This contrasts with canine Cushing's disease, which shows clear breed predilections. Domestic shorthair and domestic longhair cats, representing the majority of the feline population, naturally comprise most reported cases simply due to their numerical predominance rather than increased susceptibility.

Moderate-risk categories based on demographic factors rather than breed have been identified in available case reports and series. Middle-aged to older cats face higher risk, with most cases diagnosed in cats over ten years of age. Female cats appear to be affected more frequently than males in many published reports, though this sex predilection is not fully understood and may not hold true across all populations. No clear size or body type associations have been established. Cats on chronic corticosteroid therapy face risk of iatrogenic disease rather than naturally occurring tumors. Indoor versus outdoor lifestyle, diet, and other environmental factors have not been linked to disease development. The overall picture suggests that spontaneous Cushing's disease occurs somewhat randomly in the aging cat population.

Screening recommendations for cats cannot be as targeted as in conditions with clear breed predispositions. General wellness screening in older cats includes blood work that may reveal abnormalities suggesting Cushing's disease. Owners should monitor for characteristic symptoms including increased thirst and urination, changes in appetite or weight, skin and coat changes, and developing pot-belly appearance. Cats on chronic corticosteroid therapy warrant monitoring for iatrogenic Cushing's symptoms. When symptoms suggesting Cushing's disease appear, prompt veterinary evaluation enables early diagnosis. The lack of identified high-risk populations means that awareness of symptoms rather than targeted breed screening represents the primary early detection strategy.

Commonly co-occurring conditions with feline hyperadrenocorticism create a complex clinical picture requiring comprehensive management. Diabetes mellitus occurs in the majority of cats with Cushing's disease, with estimates suggesting eighty percent or more are affected. This high rate reflects the insulin-antagonizing effects of chronic cortisol excess, making concurrent diabetes nearly a defining feature of feline Cushing's syndrome. Managing diabetes in the context of Cushing's disease presents challenges, as insulin requirements fluctuate with cortisol levels. Hypertension commonly develops and may require specific treatment. Chronic urinary tract infections occur frequently due to immunosuppression and glucosuria providing a bacterial growth medium. Skin infections likewise reflect impaired immune function. These concurrent conditions must be addressed alongside the underlying Cushing's disease for optimal patient care.

Conditions with similar symptoms require differentiation from hyperadrenocorticism to ensure appropriate treatment. Diabetes mellitus alone shares many symptoms including increased thirst, urination, and appetite, and since most cats with Cushing's have concurrent diabetes, distinguishing the contribution of each condition can be challenging. Hyperthyroidism causes weight loss, increased appetite, and metabolic derangements in older cats. Chronic kidney disease produces polyuria and polydipsia. Acromegaly, another rare feline endocrine disorder, causes similar metabolic disturbances and diabetes. Dermatological conditions may mimic the skin changes of Cushing's disease. Thorough diagnostic evaluation including hormone testing differentiates these conditions, though some may coexist.

Potential complications arising from hyperadrenocorticism or its treatment require monitoring and management. Diabetic ketoacidosis may develop if diabetes becomes severely uncontrolled. Severe skin fragility can lead to extensive wounds requiring intensive wound care. Secondary infections may become serious in immunocompromised patients. Pituitary macroadenomas may enlarge and cause neurological signs including behavior changes, visual deficits, or seizures. Thromboembolism is a recognized risk in cats with Cushing's disease. Treatment complications include adrenal crisis if cortisol drops too rapidly with medical therapy, or surgical complications for cats undergoing adrenalectomy. Careful monitoring during treatment enables early detection and management of these potential complications.